Erasca to Present at Upcoming Conferences in November

SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will participate in the following investor conferences in November 2026 and will also participate in one-on-one investor meetings at each of these conferences.

Guggenheim 3rd Annual Healthcare Innovation Conference
Location: InterContinental Boston, Boston, MA
Format: Fireside Chat
Date and Time: Tuesday, November 10, 3:30 pm Eastern Time

Stifel 2026 Healthcare Conference
Location: Lotte New York Palace, New York, NY
Format: Fireside Chat
Date and Time: Wednesday, November 11, 9:20 am Eastern Time

Jefferies Global Healthcare Conference
Location: The Waldorf Hilton, London, UK
Format: Fireside Chat
Date and Time: Wednesday, November 18, 12:30 pm Greenwich Mean Time

A live audio webcast of the events will be available online at Erasca.com/events. An archived replay of the events will be available for 30 days following the webcast at Erasca.com/events.

About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of patients with cancer. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.

Contact:
Joyce Allaire
LifeSci Advisors, LLC
[email protected]

Media Contact:
Michael Fitzhugh
LifeSci Communications
[email protected]

You May Also Be Interested In

• DOX Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud Against Amdocs Limited
• 2026 Results of Annual General Meeting
• Tech Data Partners with SISA to Expand Cybersecurity Capabilities Across India